-
Optimization of NK cell-based cancer therapies
Toffoli, E. C., 11 Jun 2024, 260 p.Research output: PhD thesis › Thesis, fully internal
-
Nanobody-Fc constructs targeting chemokine receptor CXCR4 potently inhibit signaling and CXCR4-mediated HIV-entry and induce antibody effector functions
Bobkov, V., Zarca, A. M., Van Hout, A., Arimont, M., Doijen, J., Toffoli, E., Klarenbeek, A., van der Woning, B., Van Loy, T., de Haard, H., Schols, D., Heukers, R. & Smit, M. J., Dec 2018, In: Biochemical Pharmacology. 158, p. 413-424 12 p.Research output: Contribution to journal › Article* › Academic › peer-review
- All publications
